WebDisclosure WebDisclosure
Basculer en Français
11297 Companies
251089 Keywords
180022 Articles
136921 Press releases
Headlines Articles Press releases Telomir Pharmaceuticals, Inc Remove
  1. Home
  2. Companies
  3. Telomir Pharmaceuticals, Inc
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 08/20/2024 at 13:35, 2 years 2 months ago

    La pilule anti-âge de Telomir Pharmaceuticals montre des résultats prometteurs chez les chiens âgés

    Telomir-1 Inversion De L'âge La Science De La Longévité Chiens Âgés Améliorations De La Santé
  • PRESS RELEASE

    published on 08/20/2024 at 13:30, 2 years 2 months ago

    Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs

    Telomir-1, a small molecule by Telomir Pharmaceuticals, shows promising results in promoting life quality and longevity in senior dogs. The pre-clinical-stage company's research aims to lead developments in longevity science through the treatment of age-related conditions
    Telomir-1 Age Reversal Longevity Science Senior Dogs Pre-clinical Stage
    Logo of Telomir Pharmaceuticals, Inc
Previous page
1 ... 10 11
Accesswire
  • Published on 11/09/2026 at 14:15, 10 minutes ago

    Jericho Energy Ventures to Participate in Cantor Convergence 4th Annual Crypto and AI Infrastructure Conference

  • Published on 11/09/2026 at 14:00, 25 minutes ago

    Tectonic Metals Adds Mine Development and Alaska Native Partnership Leaders Ahead of 2027 Mineral Resource Estimate and Preliminary Economic Assessment

  • Published on 11/09/2026 at 13:35, 50 minutes ago

    Gabriel Provides Corporate Update

  • Published on 11/09/2026 at 13:30, 55 minutes ago

    Meta Critical Minerals Accepts Invitation to Join Critical Minerals Consortium at the U.S. Military Academy at West Point

  • Published on 11/09/2026 at 13:01, 1 hour 24 minutes ago

    CoTec Holdings Corp. Notes HyProMag USA Advances North Texas Rare Earth Magnet Facility With First Major Equipment Delivery

View all ACCESSWIRE
EQS Group
  • Published on 11/09/2026 at 14:08, 17 minutes ago

    Elmos Semiconductor SE wins “European Innovator of the Year 2026” with its Quantum Random Number Generator (QRNG)

  • Published on 11/09/2026 at 14:05, 20 minutes ago

    Royal Bank of Canada announces agreement to acquire Yarra Capital Management

  • Published on 11/09/2026 at 13:45, 40 minutes ago

    Form 8.3 - Zürcher Kantonalbank: Irish Residential Properties REIT plc

  • Published on 11/09/2026 at 13:35, 50 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 11/09/2026 at 13:05, 1 hour 20 minutes ago

    AUCTION OPENS FOR MICHAEL JACKSON, PRINCESS DIANA & POP CULTURE LEGENDS AS JULIEN'S HEADS TO ABU DHABI

View all EQS
Les Echos
  • Published on 11/09/2026 at 10:32, 3 hours 53 minutes ago

    Disclosure of shares outstanding and voting rights - 09.11.2026

  • Published on 11/09/2026 at 10:32, 3 hours 53 minutes ago

    Déclaration nombre d'actions et droits de vote - 09.11.2026

  • Published on 11/09/2026 at 07:00, 7 hours 25 minutes ago

    bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus

  • Published on 11/09/2026 at 07:00, 7 hours 25 minutes ago

    BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA

  • Published on 11/09/2026 at 07:00, 7 hours 25 minutes ago

    Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy